Unknown

Dataset Information

0

Identification of the genomic insertion site of Pmel-1 TCR ? and ? transgenes by next-generation sequencing.


ABSTRACT: The pmel-1 T cell receptor transgenic mouse has been extensively employed as an ideal model system to study the mechanisms of tumor immunology, CD8+ T cell differentiation, autoimmunity and adoptive immunotherapy. The 'zygosity' of the transgene affects the transgene expression levels and may compromise optimal breeding scheme design. However, the integration sites for the pmel-1 mouse have remained uncharacterized. This is also true for many other commonly used transgenic mice created before the modern era of rapid and inexpensive next-generation sequencing. Here, we show that whole genome sequencing can be used to determine the exact pmel-1 genomic integration site, even with relatively 'shallow' (8X) coverage. The results were used to develop a validated polymerase chain reaction-based genotyping assay. For the first time, we provide a quick and convenient polymerase chain reaction method to determine the dosage of pmel-1 transgene for this freely and publically available mouse resource. We also demonstrate that next-generation sequencing provides a feasible approach for mapping foreign DNA integration sites, even when information of the original vector sequences is only partially known.

SUBMITTER: Ji Y 

PROVIDER: S-EPMC4020793 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing.

Ji Yun Y   Abrams Natalie N   Zhu Wei W   Salinas Eddie E   Yu Zhiya Z   Palmer Douglas C DC   Jailwala Parthav P   Franco Zulmarie Z   Roychoudhuri Rahul R   Stahlberg Eric E   Gattinoni Luca L   Restifo Nicholas P NP  

PloS one 20140514 5


The pmel-1 T cell receptor transgenic mouse has been extensively employed as an ideal model system to study the mechanisms of tumor immunology, CD8+ T cell differentiation, autoimmunity and adoptive immunotherapy. The 'zygosity' of the transgene affects the transgene expression levels and may compromise optimal breeding scheme design. However, the integration sites for the pmel-1 mouse have remained uncharacterized. This is also true for many other commonly used transgenic mice created before th  ...[more]

Similar Datasets

| S-EPMC4225161 | biostudies-literature
2017-04-03 | PXD003804 | Pride
| S-EPMC4735785 | biostudies-other
| S-EPMC4265454 | biostudies-literature
| S-EPMC3633056 | biostudies-literature
| S-EPMC7667365 | biostudies-literature
| S-EPMC11195097 | biostudies-literature
| S-EPMC11317131 | biostudies-literature
| S-EPMC4136736 | biostudies-literature
| S-EPMC10169431 | biostudies-literature